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Urinary tract infections (UTIs) are one of the most common human bacterial infections.
While UTIs are commonly associated with colonization by Escherichia coli, members
of this species also have been found within the bladder of individuals with no lower
urinary tract symptoms (no LUTS), also known as asymptomatic bacteriuria. Prior
studies have found that both uropathogenic E. coli (UPEC) strains and E. coli isolates
that are not associated with UTIs encode for virulence factors. Thus, the reason(s)
why E. coli sometimes causes UTI-like symptoms remain(s) elusive. In this study, the
genomes of 66 E. coli isolates from adult female bladders were sequenced. These
isolates were collected from four cohorts, including women: (1) without lower urinary
tract symptoms, (2) overactive bladder symptoms, (3) urgency urinary incontinence,
and (4) a clinical diagnosis of UTI. Comparative genomic analyses were conducted,
including core and accessory genome analyses, virulence and motility gene analyses,
and antibiotic resistance prediction and testing. We found that the genomic content of
these 66 E. coli isolates does not correspond with the participant’s symptom status. We
thus looked beyond the E. coli genomes to the composition of the entire urobiome and
found that the presence of E. coli alone was not sufficient to distinguish between the
urobiomes of individuals with UTI and those with no LUTS. Because E. coli presence,
abundance, and genomic content appear to be weak predictors of UTI status, we
hypothesize that UTI symptoms associated with detection of E. coli are more likely the
result of urobiome composition.
Keywords: E. coli, UPEC, UTI, urinary microbiome, urobiome
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INTRODUCTION
Urinary tract infections (UTIs) affect about 150 million people
per year, mounting large medical costs for individuals and
communities (Flores-Mireles et al., 2015). While several different
bacterial species are known to cause UTIs, the most frequent
culprit is uropathogenic E. coli (UPEC), which is thought to
account for up to 74.4% of all community-acquired infections
(Foxman, 2014). Phylogenomic studies have placed UPEC strains
amongst multiple E. coli phylotypes (Moriel et al., 2016).
Genome sequencing of UPEC isolates has identified numerous
virulence factors and pathogenicity islands (Subashchandrabose
and Mobley, 2015; Moriel et al., 2016; Terlizzi et al., 2017).
Transcriptome analyses have revealed high expression of genes
associated with copper efflux and potassium/nickel transport in
patients with UTIs (see review; Subashchandrabose et al., 2014).
Nevertheless, the UPEC genomic “signature” remains elusive
(Johnson et al., 2001, 2015; Luo et al., 2012). At present, there
is evidence that the pathogenic potential of E. coli cannot be
predicted from the presence of specific genetic content, such as a
distinct virulence factor. Instead, UTI may be a result of multiple
variables (Eto et al., 2007; Ragnarsdóttir et al., 2011; Brubaker and
Wolfe, 2017; Schreiber et al., 2017).
Previous evidence indicates that the gut of individuals can
be a reservoir for E. coli and thus a source of UTI (Yamamoto
et al., 1997; Nielsen et al., 2014). Evidence shows that flagellum-
mediated motility is key during E. coli ascension into and
colonization of the urinary tract (Lane et al., 2007). Furthermore,
it has been shown that UPEC strains are able to colonize both
the gut and urinary tract (Chen et al., 2013). E. coli strains
isolated from fecal and urine samples of women with UTIs have
been found to have similar genomes, and in the absence of
symptoms, they cannot be distinguished (Nielsen et al., 2017).
This supports the prevailing hypothesis that UTIs can be the
result of colonization of the urinary tract by E. coli strains from
the gut (Yamamoto et al., 1997; Hooton, 2001; Chen et al., 2013;
Thänert et al., 2019).
However, the current UTI paradigm does not account for the
human urinary microbiota (urobiome) – the newly discovered
communities of microbes (bacteria, archaea, protists, fungi,
and viruses) that inhabit the bladder. Consequently, traditional
clinical care methods remain based on dogma that “urine
is sterile.” High throughput DNA sequencing and improved
urine culture techniques reveal bacterial DNA and live bacteria,
respectively, in catheterized (bladder) urine deemed culture-
negative by the standard urine culture method (Fouts et al.,
2012; Wolfe et al., 2012; Khasriya et al., 2013; Brubaker
et al., 2014; Hilt et al., 2014; Nienhouse et al., 2014; Pearce
et al., 2014, 2015; Karstens et al., 2016; Price et al., 2016;
Thomas-White et al., 2016, 2017; Coorevits et al., 2017). The
urobiome of women without lower urinary tract symptoms
(LUTS) often includes species of the genera Lactobacillus,
Corynebacterium, Gardnerella, Staphylococcus, and Streptococcus
(see review; Brubaker and Wolfe, 2017). Traditionally, it has
been thought that the incidence of E. coli in the urinary
tract necessitated infection and symptoms, but the discovery
of the urobiome and isolation of E. coli in asymptomatic
people indicates otherwise (Thomas-White et al., 2018b; Price
et al., 2020). Moreover, the native microbiota of the bladder
has been shown to be distinct from the gastrointestinal tract
(Thomas-White et al., 2018a; Price et al., 2020). Thus, a UTI
may not always be due to a uropathogen invasion; instead,
the urinary tract could itself be the source of UPEC strains.
This has been shown previously in individuals with recurrent
UTIs (Mysorekar and Hultgren, 2006; Thänert et al., 2019).
UTI also could be due to commensal E. coli being overly
abundant and/or disproportionate to other commensals in
the urinary tract.
Here, we present a study of 66 E. coli strains isolated from the
bladders of women with or without a UTI diagnosis; the latter
cohort was further subdivided into women with no lower urinary
tract symptoms (no LUTS), overactive bladder (OAB), or urgency
urinary incontinence (UUI). Genomes of each of these strains
were sequenced. We then compared the evolutionary history,
encoded virulence factors, and antibiotic sensitivity of each of
these strains in order to identify any factors that distinguish
strains associated with patient symptoms. Furthermore, we
expanded our analyses to look not only at E. coli as the signature
of a UTI, but rather the entire microbial community.
MATERIALS AND METHODS
Patient Recruitment
Participant sampling for this study was through several
different Institutional Review Board-approved studies [Loyola
University Chicago (LU203986, LU205650, LU206449,
LU206469, LU207102, and LU207152) and University of
California San Diego (170077AW)]. Participants gave verbal and
written consent for chart abstraction and urine collection with
analysis for research purposes. Members of the Loyola Urinary
Education and Research Collaborative (LUEREC), specifically
clinicians from the Female Pelvic Medicine and Reconstructive
Surgery Center at Loyola University Medical Campus (LUMC),
performed recruitment and urine collection. Participants were
recruited as a part of separate studies (Hilt et al., 2014; Pearce
et al., 2014, 2015; Price et al., 2016, 2020; Thomas-White et al.,
2016, 2018a; Dune et al., 2017).
The symptoms of some of the women in the OAB and
UUI groups were characterized with the validated Pelvic Floor
Distress Inventory symptom questionnaire (Uebersax et al.,
1995; Barber et al., 2001). The entire OAB cohort completed
the Overactive Bladder Questionnaire (Coyne et al., 2002).
For the OAB and UUI cohorts, women with a current UTI
(based on urine dipstick test) or a history of recurrent UTI
were excluded. For the UTI cohort, participants included
women who responded affirmatively to the question “Do you
feel you have a UTI?” and completed the UTI symptom
assessment (UTISA) questionnaire (Clayson et al., 2005).
All UTI samples were from women with cystitis (bladder
infection). To be a member of the no LUTS cohort, women
had to respond no to this question and be free of LUTS
based on the Pelvic Floor Distress Inventory symptom and
Overactive Bladder questionnaires. For all studies, exclusion
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criteria included age of <18 years, pregnancy, catheterization
(indwelling or intermittent), or insufficient English skills to
complete study measures.
Urine Collection and EQUC Bacterial
Culturing
Urine was collected aseptically via transurethral catheter and
was placed in a BD Vacutainer Plus C&S preservative tube for
culturing. This technique bypasses the vulva, vagina, and urethra,
thus resulting in samples of bacterial isolates specifically from
the bladder niche (Wolfe et al., 2012). All samples underwent
standard urine culture (SUC), as well as expanded quantitative
urine culture (EQUC), as part of the aforementioned studies
(Hilt et al., 2014; Pearce et al., 2014, 2015; Price et al., 2016,
2020; Thomas-White et al., 2016, 2018a; Dune et al., 2017). For
SUC, 1 µL of urine was inoculated onto 5% sheep blood agar
plate (BAP) and MacConkey agar plate (BD BBL prepared plated
media), and incubated aerobically at 35◦C for 24 h. The detection
level was 1000 colony forming unit (CFU) per mL, represented
by 1 colony of growth on either plate. EQUC was performed as
described previously (Hilt et al., 2014). Briefly, 100 µL of urine
was grown under five conditions with BD BBL prepared plated
media: (1) BAP in CO2 for 48 h, (2) chocolate agar (CHOC) in
CO2 for 48 h, (3) colistin and nalidixic acid (CNA) agar in CO2
for 48 h, (4) CDC anaerobe BAP in an anaerobic jar for 48 h, and
(5) BAP in aerobic conditions (BD GasPak Anaerobe Sachets) for
48 h. The detection level was 10 CFU/mL, represented by 1 colony
of growth on any of the plates.
Pure cultures were obtained by isolating each morphologically
distinct colony type on a different plate of the same medium.
Matrix-assisted laser desorption ionization-time of flight
(MALDI-TOF) mass spectrophotometry with the MALDI
Biotyper 3.0 software program (Bruker Daltonics, Billerica, MA,
United States) was used to identify the bacterial strains (see Hilt
et al., 2014 for specific protocol, the same as is recommended by
the Clinical Laboratory Standards Institute). For some of these
isolates, 16S rRNA gene sequencing was performed to verify
MALDI-TOF classifications. Previous work by our group showed
a concordance between MALDI-TOF and 16S rRNA sequencing
classification of urinary isolates (Pearce et al., 2014; Price et al.,
2020). Strains identified as E. coli via MALDI-TOF were grown
from single colonies in lysogeny (LB) broth (10.0 g/L tryptone,
5.0 g/L yeast, 10.0 g/L NaCl). Stocks of each strain were made
using 900 µL 50% glycerol mixed with 90 µL E. coli cells, and
stored at −80◦C.
DNA Extraction and Genome Sequencing
Liquid cultures of each strain (Supplementary Table 1) were
grown from freezer stock in LB at 37◦C in a shaking (150 rpm)
incubator for 12 h. DNA was extracted from liquid culture
using the Qiagen DNeasy UltraClean Microbial Kit following
the manufacturer’s protocol. DNA concentration was quantified
using the Qubit fluorometer. To confirm the MALDI-TOF
classification, the 16S rRNA gene sequence was amplified using
the 63f and 1387r primers (Marchesi et al., 1998) and sequenced
by Genewiz (New Brunswick, NJ, United States), using each
primer individually for 2× coverage. The resulting sequences
were manually trimmed and paired in Geneious v11.0.5
(Biomatters, Ltd., Auckland, New Zealand) and queried against
the NCBI 16S rRNA sequences database via blastn to confirm
that they were E. coli. DNA libraries were constructed using
the Nextera XT DNA Library preparation kit and sequenced
on the Illumina MiSeq platform using the MiSeq Reagent
Kit v2 (500-cycles) at Loyola University Chicago’s Genomics
Facility (Maywood, IL United States). Raw sequencing reads were
deposited in NCBI’s SRA database.
Assembly and Annotation
Raw reads were first trimmed for quality using the tool Sickle
v1.331 and then assembled with SPAdes v3.10.1 using the
assembly-only option for k values of 55, 77, 99, and 127
(Bankevich et al., 2012). Contigs less than 500 nucleotides in
length were removed from further consideration. Assembled
contigs were then manually inspected and individually queried
against the nr/nt database via megablast, confirming that no
contaminants were included in the sequence data. The genome
coverage of each assembly was calculated using BBMap’s bbwrap
and pileup scripts2. Each assembly was annotated using the
NCBI Prokaryotic Genome Annotation Pipeline (PGAP) v4.7
(Tatusova et al., 2016).
Assemblies were evaluated for additional genomic features.
The E. coli serotype was determined using SerotypeFinder
v2.0 using default parameters (threshold ID = 85%; minimum
length = 60%) (Joensen et al., 2015). The EzClermont web
application was used to phylotype each genome (Waters
et al., 2020). Genome assemblies were scanned for plasmid
replicon sequences using PlasmidFinder v2.1 with default
settings (threshold ID = 95%; minimum% coverage = 60%)
(Carattoli et al., 2014). All genomes are publicly available
through NCBI’s Assembly database (Supplementary Table 2).
Virulence factors present within each genome were identified
using the virulence factor database (VFDB) using VFanalyzer
(Liu et al., 2019). Genes for flagellar synthesis, flagellar rotation,
chemotactic signal transduction, and chemotactic membrane
receptors were identified within the genome sequences using
reciprocal blasts and manual curation. Local blast databases
were made using the PGAP annotation files and flg (flgA-flgN),
flh (flhA-flhE), fli (fliA, fliC-fliT, and fliZ), mot (motA, motB)
and che (cheA, cheB, cheR, cheW, cheY, and cheZ) genes as
well as chemotactic receptors tap, tar, trg, tsr, and aer were
identified. These sequences were manually inspected. Antibiotic
resistance prediction was conducted using ResFinder v3.2 using
the default settings (threshold ID = 90%; minimum length = 60%)
(Zankari et al., 2012).
Core Genome and Phylogenomic
Analysis
Amino acid sequences for each genome’s RefSeq annotation
derived by PGAP were concatenated into a single FASTA format
file, sorted by length, and clustered using usearch via the
1https://github.com/najoshi/sickle
2https://sourceforge.net/projects/bbmap/
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cluster_fast method (Edgar, 2010). Sequence identity thresholds
of 70, 80, and 90% were tested; the clusters generated for 80%
were selected for further analysis. After manual inspection to
confirm homologs were properly identified, the average sequence
identity was confirmed to be >90%. The final set of clusters were
next parsed using Python to generate a gene presence/absence
matrix for the genomes. Using this matrix, hierarchical clustering
was performed with SciPy3 and the Ward variance minimization
algorithm. The resulting tree was converted to Newick format
and visualized using iTOL (Letunic and Bork, 2016). This matrix
also was used to identify genes belonging to the core and
accessory genomes for the 66 E. coli. For each gene within
the core genome set, the sequences were aligned using MAFFT
and alignments were manually inspected (Katoh and Standley,
2013). A consensus tree was derived by first concatenating
the alignments followed by derivation using FastTree (Price
et al., 2010). The resulting tree was visualized using iTOL
(Letunic and Bork, 2016).
Antibiotic Susceptibility Testing
Antibiotics frequently prescribed for UTI treatment were tested
(Chu and Lowder, 2018). Using BBLTM Sensi-Discs (Becton,
Dickinson and Company; Franklin Lakes, NJ), each strain was
tested for its susceptibility to fosfomycin (200 µg, BD 231709),
ciprofloxacin (5 µg, BD 231657), amoxicillin with clavulanic
acid (20/10 µg; BD 231628), sulfamethoxazole-trimethoprim
(23.75/1.25 µg; BD 231536) and cefpodoxime (10 µg; BD
231673). Testing was conducted as follows. Each E. coli strain
was incubated in 3 mL of LB broth overnight aerobically, shaking
at 37◦C. 1 mL was spread on a 1.7% LB agar plate using a
cell spreader and left to dry for 5 m. Sensi-Discs were then
placed on the E. coli lawn using sterile forceps and the plates
were incubated overnight at 37◦C. The clearance diameter was
measured for each Sensi-Disc and each antibiotic was tested
in triplicate for each E. coli strain. Based upon the diameter
measured, the manufacturer’s instructions were used to classify
strains as resistant, intermediate, or susceptible.
Comparing Bladder E. coli Isolates to
Publicly Available Genomes
Each of the 66 bladder E. coli genome assemblies was compared
to NCBI’s nr/nt database via megablast. The assembled contigs
for each genome assembly were concatenated such that the entire
genome sequence was queried. The top hit was recorded for each
and the source for the top hit was determined from the GenBank
record and/or the literature.
Statistical Analysis of Communities
The CFU/mL count for all bacteria in each of the 63 independent
samples containing one of the sequenced E. coli genomes were
examined. The individual contributing 3 isolates to our collection
of E. coli genomes (UMB6653, UMB6721, and UMB7431)
was removed from consideration as they are not independent
samples. In addition to these data, we included CFU/mL counts
3www.scipy.org
for the urobiomes that we have previously characterized from
samples of women with UTI symptoms and women without
LUTS. In total, this resulted in 109 participants with UTI
symptoms and 90 participants with no LUTS. CFU/mL data
was recorded at the genus level rather than the species level for
our analysis. To analyze prevalence of UTI among participants,
a multiple logistic regression model (Cramer, 2002) was used.
We treated the no LUTS group as our baseline category for
the UTI group. For each participant, abundances of 27 different
bacteria were measured; genera appearing in only one sample
were removed from consideration. Abundance of these 27 species
of bacteria were treated as covariates in our model. Akaike
Information Criterion (AIC) (Akaike, 1974; Aho et al., 2014) was
used to reduce the full model. All analyses were conducted in R4.
RESULTS
Sixty-six E. coli isolates were investigated here, each isolated
using the EQUC method from catheterized urine samples from
women with (n = 42) or without (n = 24) a clinical diagnosis
of UTI. These isolates were collected from 64 different women
as one individual with a recurrent UTI was sampled three
times [E. coli strains UMB6653 (first visit), UMB6721 (second
visit), and UMB7431 (third visit)]. The non-UTI group included
asymptomatic ‘healthy’ women [the “no LUTS” group (n = 6)] as
well as women with OAB (n = 5) or UUI (n = 13). Supplementary
Table 1 lists each isolate and participant symptom diagnosis,
as well as the abundance of E. coli relative to isolates of other
species within the catheterized urine specimens. These data
revealed that the abundance of E. coli does not strictly relate
to diagnostic group, as the UTI group included 6 individuals
with low abundances (<10,000 CFU/mL) of E. coli within their
bladder microbiota, whereas the non-UTI group included 9
individuals with high E. coli abundances (≥100,000 CFU/mL).
Whole genome sequencing, genome assembly, and annotation
were performed for each isolate (see section “Materials and
Methods”). Supplementary Table 2 lists the genome assembly
statistics. The genomes ranged in size from 4.6 to 5.6 Mbp. Each
genome is represented by long, high quality contig sequences.
The average assembly consisted of 73 contigs, ranging from
E. coli isolate UMB6454 (33 contigs) to E. coli isolate UMB2019
(161 contigs). The serotype and phylotypes were determined for
each strain (Supplementary Table 1). The genomes represent 39
different serotypes. While most (n = 36) isolates belong to the B2
phylotype, 20 isolates belong to phylotype D, 5 to phylotype A,
4 to phylotype B1, and 1 to phylotype F. 59 of the 66 genomes
included a contig(s) with a replicon sequence, suggesting that
many isolates included plasmid sequences (Supplementary
Table 2). Contigs showing similarity to the Col156, IncFII, and
IncFIB plasmid replicons were the most abundant, with 28, 45,
and 41 isolates harboring these plasmids, respectively.
The core genome of these isolates contained 2,814 genes. This
is significantly smaller than the pangenome, which contained an
additional 10,182 genes present in one or more of the isolates.
4https://www.R-project.org/
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However, 28% of the pangenome consists of genes that were only
found within one of the 66 E. coli genomes, reinforcing prior
claims that E. coli has an open genome (Rasko et al., 2008).
From the core genome, we constructed a phylogenomic tree
(Figure 1). The 66 isolates belong to two distinct clades: the
isolates belonging to the B2 phylotype and the isolates belonging
to the A, B1, D, and F phylotypes. Symptom status was not
associated with these clades; there is no evolutionary distinction
between E. coli isolates associated with UTI symptoms and those
that are not. While the no LUTS isolates were only found within
the bottom clade, the sample size is too small to draw conclusions
from this observation. In addition to the clear distinction between
phylotypes, members of the same serotype often had the most
similar core genome sequences.
Next we performed hierarchical clustering of the genes from
the pangenome to ascertain if genome content was associated
with symptom status (Figure 2). Here, genomes that share more
genes in common cluster together. Again, we observed two
major clades. Each isolate clustered within the same major clade
based on gene content (Figure 2) as it did based on the core
genome sequence (Figure 1). The clading structure, however, is
not identical; for example, the single isolate in phylotype F, E. coli
UMB0103, is no longer distinct from the isolates of phylotype D.
Further comparison of these two trees reveals that some isolates
are more similar with respect to their core gene sequences than
they are with respect to the accessory genes that they contain.
Using the gene presence matrix, the correlation between each
gene’s presence/absence in the 66 E. coli genomes and the patient’s
clinical diagnosis was calculated. Genes were found to have no or
a weak correlation (r < 0.5) to clinical diagnosis.
From the accessory genome alone, we first considered the
770 genes present in ≥80% of the UTI genomes and found
that these genes were often present (≥50%) in the genomes
from participants of the non-UTI symptom groups. There are
no genes frequently present (≥80%) in the UTI genomes that
are also absent from the non-UTI genomes. Only the gene that
encodes the anti-adaptor protein IraD, which inhibits RssB-
mediated degradation of RpoS (Battesti et al., 2011; Park et al.,
2017), was frequently present in the UTI genomes (86%) and
found in only 50% of the non-UTI genomes. All other genes
meeting the ≥80% threshold of presence within the UTI genomes
were also present in more than half of the non-UTI genomes. In
contrast, three genes were underrepresented within the no LUTS
group. The genes that encode the type II toxin-antitoxin system
YhaV/PrlF and the type I toxin Hok were frequently present in
the UTI genomes (≥85%). The genes that encode the YhaV/PrlF
system were present in all of the genomes from OAB and UUI
participants (n = 18) and Hok was present in most of the OAB
and UUI participants (n = 15).
To further investigate the putative pathogenicity of the
isolates, each genome was queried against the virulence factor
database (VFDB), identifying 242 different virulence genes
(associated with 99 virulence factors) amongst the 66 isolates
(Supplementary Table 3). The only virulence factors found in
all 42 UTI genomes were also found in all non-UTI (no LUTS,
OAB, and UUI) genomes and included: Hemorrhagic E. coli pilus
(related genes hcpA and hcpC), Type I fimbriae (related genes
fimF, fimG, and fimH), enterohemorrhagic E. coli autotransporter
B (related gene ehaB), and invasion of brain endothelial cells
(related genes ibeB and ibeC). While there were no virulence
factors found frequently and exclusively in the UTI isolates, the
E. coli laminin-binding fimbriae (ELF) and non-LEE type III
secretion system effector (TTSS) virulence factors were often
present (30 and 40%, respectively) in UTI isolates and absent in
all of the no LUTS isolates. However, genes related with these
virulence factors were identified in OAB and UUI genomes. No
association between virulence factors and symptom state be it
UTI/non-UTI or UTI/OAB/UUI/no LUTS was identified.
To evaluate the hypothesis that UTIs can be the result of
colonization of the urinary tract by E. coli strains from the
gut, we examined the genome annotations for the presence
of 52 genes associated with flagellar synthesis (flg, flh, and
fli), flagellar rotation (mot), chemotactic signal transduction
(che), and chemotactic membrane receptors (tar, tsr, tap, trg,
and aer) (see section “Materials and Methods”). Twenty-four
of the genomes contained all of the genes and at least one
chemoreceptor, suggesting that these isolates are flagellated,
motile, and chemotactic (Table 1). While all 66 genomes encode
for the flh, mot, and che genes, the remaining 42 isolates are
lacking one or more flg and/or fli genes. All 66 genomes include
the tsr, tar, and trg chemoreceptors. UMB0276 is the only genome
lacking the aer chemoreceptor and 36 lack the tap chemoreceptor
(Supplementary Table 4).
Next, we considered pathogenicity relative to antibiotic
resistance. Antibiotic resistance was predicted from the genome
sequences (Supplementary Table 5). Genes associated with
resistances to aminoglycosides, beta-lactams, macrolides,
phenicol, quinolone, rifampicin, sulfonamides, tetracyclines,
and trimethoprims were detected amongst the isolates. Most
(85%) of these genes were chromosomal-mediated; only 21
strains carried plasmids encoding for an antibiotic resistance
gene (Supplementary Table 5). While only UTI isolates encoded
genes associated with phenicol (n = 2) and rifampicin (n = 1), all
other resistances were observed in the genomes from both UTI
and non-UTI isolates. Next, five antibiotics routinely prescribed
for UTIs were tested: fosfomycin, ciprofloxacin, amoxicillin
with clavulanic acid, sulfamethoxazole-trimethoprim, and
cefpodoxime. Concurring with the genomic analysis, all of the
isolates were sensitive to fosfomycin (Table 2). However, as
indicated in Supplementary Table 6, computational predictions
and experimental results were often discordant, e.g., resistance
to ciprofloxacin was observed for 16 isolates even though
quinolone resistance was only predicted for three isolates.
Four of the isolates [UMB0731 (OAB) and UMB1193 (UTI),
UMB1335 (UTI), and UMB1348 (UTI)] were sensitive to all
five antibiotics tested. Statistical analysis found that sensitivity
varied between non-UTI and UTI isolates by drug (p = 0.0086).
Non-UTI isolates were more resistant to amoxicillin than UTI
isolates and more sensitive to sulfamethoxazole-trimethoprim
than UTI isolates. However, the variation in sensitivity between
non-UTI and UTI isolates or amongst no LUTS, OAB, and
UUI isolates was not statistically significant (p = 0.9682 and
0.8313, respectively).
As prior studies have attributed the gastrointestinal (GI) tract
as the source of UPEC strains, we next sought to compare our
66 bladder isolates with all publicly available E. coli genomes.
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FIGURE 1 | Phlyogenomic relationship of the 66 UTI (red) and non-UTI E. coli isolates from the bladder. Non-UTI symptom groups are indicated by color. Phylotypes
are indicated by the colored boxes. The branch labeled with a star indicates the 3 isolates of the subphylotype B22. Serotypes for each isolate are listed next to the
isolate name. Branch supports are shown.
It is important to note that many of the genomes deposited in
GenBank were isolated either from the GI tract or from urine
collected by an unspecified method during a UTI. The bladder
isolates aligned to E. coli genomes in NCBI’s nr/nt database
with 83–98% query coverage (Supplementary Table 7). These
hits included isolates from urine (n = 24) and stool (n = 17)
of humans, canines, cattle, mice, birds, and pigs (Table 3).
Two isolates, UMB0149 (OAB) and UMB2019 (UUI), exhibited
greatest similarity to isolates from forest soil and hospital
wastewater, respectively (Supplementary Table 7).
Because our results suggest that the E. coli genome itself does
not correspond with UTI symptoms, we next considered the
E. coli isolates as a member of the bladder community. During
the isolation of each these E. coli isolates, other bacterial taxa
of the urobiome were also identified (Supplementary Table 8).
As Figure 3 shows, several different species were found within
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FIGURE 2 | Hierarchical clustering of the 66 E. coli genomes based on gene content. Symptom groups are indicated by color. Phylotypes are indicated by the
colored boxes. The branch labeled with a star indicates the 3 isolates of the subphylotype B22.
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TABLE 1 | Number of genomes encoding for all flg, flh, fli, mot, and che genes, as
well as at least one chemoreceptor.
Symptom group # Genomes encoding for all
flagellar and chemotaxis genes
no LUTS (n = 6) 1
OAB (n = 5) 0
UUI (n = 13) 5
UTI (n = 42) 18
TABLE 2 | Percentage of E. coli isolates resistant or sensitive to the antibiotics
fosfomycin (FOF), ciprofloxacin (CIP), amoxicillin with clavulanic acid (AMC),




FOF CIP AMC SXT CPD
Resistant no LUTS
(n = 6)
0 67 0 50 17
OAB (n = 5) 0 40 0 60 60
UUI (n = 13) 0 15 46 62 15
UTI (n = 42) 0 19 5 45 26
Sensitive no LUTS
(n = 6)
100 33 17 17 83
OAB (n = 5) 100 40 60 20 40
UUI (n = 13) 100 62 54 15 62
UTI (n = 42) 93 50 55 31 45
TABLE 3 | Isolation source of genomes most similar to the bladder E. coli isolates.








Human Urine 1 1 2 9
Stool 1 0 2 7
CSF 1 0 0 4
Blood 2 1 0 1
Unknown 0 1 3 2
Other
Species
Urine 0 1 3 7
Stool 1 0 0 6
Other 0 0 1 0
Hospital
wastewater
0 1 0 0
Soil 0 0 1 0
Unknown 0 0 1 6
the urobiomes of these women. Fifteen womens’ urobiomes
included only E. coli; only 9 of these were from UTI patients.
E. coli was the predominant member or was present in high
abundance within 18 (75%) and 9 (37.5%), respectively, of the
urobiomes of women without UTI symptoms. Within the UTI
cohort, the urobiomes of 6 women included species from the
genera Staphylococcus, Lactobacillus, Klebsiella, and Gardnerella
that were in greater abundance than E. coli. To improve the
statistical robustness of our analyses, we supplemented our
urobiome community data, including CFU/mL counts for all
constituents, for the 64 participants from which the 66 E. coli
genomes were collected with an additional 135 participant data
sets for a total of 109 UTI participants and 90 non-UTI no LUTS
participants. While we found that E. coli presence was highly
significant (p-value = 1.39E-09), the effect was very small. Our
model predicted that, for a unit increase in E. coli, the expected
odds of UTI increases by 0.003%. Thus, the presence of E. coli
alone is not sufficient to distinguish between the urobiomes of
individuals with UTI and those with no LUTS.
DISCUSSION
As prior studies have shown, E. coli can be found in the bladders
of women with or without UTI symptoms (Price et al., 2016,
2020; Thomas-White et al., 2018b). Furthermore, it can be found
in abundance in women without UTI symptoms [(Price et al.,
2016); see also review (Ferroni and Taylor, 2015), shown also in
this study (Supplementary Table 1)]. The 66 E. coli genomes
sequenced and analyzed here include isolates obtained from
women with or without UTI symptoms, as well as women
with other LUTS. To our knowledge, this is the first study
that has investigated E. coli genomes from the urobiome of
women with either OAB or UUI. Prior comparative genomic
studies have focused on E. coli isolates from individuals with or
without UTI symptoms only (Rasko et al., 2008; Moriel et al.,
2016, see also review; Lo et al., 2017). We also investigated
the genomes of E. coli isolates from women without LUTS, a
scenario previously called asymptomatic bacteriuria (Rubin et al.,
1992; Nicolle, 2003; Nicolle et al., 2019). A recent study of 224
adult women without LUTS showed that E. coli is relatively
uncommon in this population, but it can be present and can
be the predominant taxon especially in older women (Price
et al., 2020). As Figures 1, 2 show, the phylogenetic history and
genomic content of E. coli isolates from women with or without
UTI does not correspond with the participant’s UTI status. While
the isolates from women with no LUTS are only found within
the B2 phylotype clade, our sample size is small. We expect
with an increased sample size that isolates would represent other
phylotypes as isolates from the non-UTI group, which includes
no LUTS, OAB, and UUI, were found in both clades of the trees.
Of the 66 isolates sequenced here, 3 were from the same
individual, a woman with recurrent UTIs. The three isolates
from this woman, UMB6653, UMB6721, and UMB7431, were
most similar to each other in the core genome phylogeny and
gene content. UMB6653 and UMB6721 are identical, according
to their core gene sequences, suggesting that the same strain is
responsible for the woman’s reinfection. This reinfection could be
the result of persistence within the bladder over time, potentially
through intracellular reservoirs, as has previously been observed
within recurrent UTI patients (Mysorekar and Hultgren, 2006;
Thänert et al., 2019). Our gene content analysis (Figure 2)
provides evidence that this strain has been evolving over time
through gene acquisition/loss; 69 genes were present in only
one isolate, whereas 86 genes were present in only two of
the three isolates.
Focusing our investigation of these genomes on characteristics
advantageous to infection and persistence, our analysis of the
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FIGURE 3 | Urobiomes from which E. coli was isolated. Each bar represents the relative abundance of microorganisms within the urobiome, color coded by species,
for the individual patient. The black circles on each stacked bar show the abundance of E. coli in the urobiome. Urobiomes are presented according to the symptom
group.
accessory genome and virulence factors once again showed no
distinction between those traits and symptom status. There was
no gene frequently present (≥80%) in the UTI genomes that
was not present in the non-UTI genomes. Prior investigations of
the E. coli accessory genome have likewise found that symptom
status and even source (urinary versus fecal) cannot reliably be
distinguished by the accessory genome (Nielsen et al., 2017).
Isolates from so-called asymptomatic bacteriuric individuals
contain virulence factors despite the lack of symptoms (Yun
et al., 2014). Here, we also have examined the genomes
of E. coli isolates that represent a small population and/or
fraction of the entire urobiome community. No distinction in
virulence factors was observed between E. coli isolates from
urobiomes in which E. coli was prevalent (≥100,000 CFU/ml)
or dominant and those for which it was not. Together,
this suggests that E. coli strains within the bladder have
the potential for virulence, although they may not presently
cause UTI symptoms.
While the E. coli genomes suggested that many of our
isolates were resistant to antibiotics, these predictions were not
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significantly different between symptom states for the 9 classes
of antibiotics considered (Supplementary Table 5). From our
subsequent testing of 5 antibiotics, distinction between antibiotic
resistance of isolates from women with or without UTI symptoms
was not statistically significant. Bioinformatic predictions showed
their limitations here. For example, more strains were resistant
to ciprofloxacin and sulfamethoxazole-trimethoprim (16 and 32,
respectively) than predicted (3 and 26, respectively). Neither
the frequency of resistance predicted or observed within the no
LUTS, OAB, and UUI cohorts suggests that E. coli strains may
persist as a minor constituent of the normal bladder flora after
antibiotic treatment because of acquired resistance.
There is evidence that the gut of individuals can be a
reservoir for E. coli and thus a source of UTI (Yamamoto et al.,
1997; Larsen et al., 2014). Without paired stool samples for
the isolates investigated here, we cannot directly determine the
source of the E. coli isolates. As a proxy, we compared the
genomes of these isolates to publicly available genome sequences
for which there are currently >19,000 from a wide variety
of sources. While the most hits (36%) were to isolates from
urine (Table 3), these only constitute ∼6.5% of the publicly
available genomes. A substantial number of hits to isolates from
stool were also observed, 10 to human stool samples and 7 to
stool samples from other animals. Colonization of the urinary
tract by a gut bacterium necessitates motility. However, only
24 of our isolates encode for all of the flagellar and motility
genes (Table 1). For example, nine isolates lack fliC, which
is required for the production of flagella (Lane et al., 2005).
Two other isolates do not encode for flgM, a situation that
hinders motility (Lane et al., 2005). Our investigation into these
flagella-related genes suggest limited if any motility. However,
as paired studies have shown, there is more than one way
a UPEC strain can cause UTI recurrence. In addition to an
external source, UPEC strains may persist within the urinary tract
(Thänert et al., 2019).
Here, we found that neither E. coli presence nor E. coli
genomic variation can predict UTI symptoms. Our analysis of
urobiome compositions found that E. coli was a weak predictor
of UTI status. Prior comparisons of urobiomes from women
with or without UTI symptoms identified several differences
in bacteria abundances including Aerococcus urinae, Klebsiella
pneumoniae, Enterococcus faecalis, E. coli, Staphylococcus aureus,
Streptococcus agalactiae, and Streptococcus anginosus (Price et al.,
2016). These taxa include several emerging uropathogens that
have increasingly been associated with UTIs (see review; Kline
and Lewis, 2016). Furthermore, UTI diagnosis based upon E. coli
abundance alone ignores recent evidence that UTI symptoms can
be the result of more than one bacterial species, also known as a
polymicrobial infection (see review; Kline and Lewis, 2016).
Because E. coli presence, abundance, and genomic content
are weak predictors of UTI status, we hypothesize that UTI
symptoms are more likely the result of multiple factors, including
the urobiome composition. The urobiome appears to protect
against post-treatment UTI (Brubaker et al., 2014; Thomas-
White et al., 2018b). For instance, we previously observed that
Lactobacillus crispatus is frequently in the urobiomes of women
with no LUTS (Pearce et al., 2014). Prior studies have found
that Lactobacilli can inhibit the growth of E. coli (Atassi et al.,
2006, 2019; Cadieux et al., 2009; Hudson et al., 2020). In contrast,
E. faecalis can promote E. coli growth under conditions for
which it would otherwise not be able to thrive (Keogh et al.,
2016). It is likely that other interactions between members
of the urobiome could inhibit or contribute to symptoms.
Metagenomic sequencing of “clean catch” urine specimens
from individuals with or without UTI symptoms has identified
urobiome compositions associated with UTIs, often dominated
by Proteobacteria (Moustafa et al., 2018). These compositions
require further investigation to identify constituents contributing
to symptoms. In addition to microbes, other factors must also
be considered, e.g., urine components (Forsyth et al., 2018;
Reitzer and Zimmern, 2019) and the human host’s genetics
(Ragnarsdóttir et al., 2011; Adebayo et al., 2020). Transcriptomic
and proteomic studies have already begun to identify transcript
and protein level changes associated with infection (Bielecki et al.,
2014; Subashchandrabose et al., 2014; Sintsova et al., 2019; see
also review; Lo et al., 2017). With the aid of these other ‘omic
technologies, the likely multiple causes of UTI symptoms can
be determined, be it a single bacterial taxon or a particular
microbial community.
The E. coli genomes, including the presence of virulence
factors and antibiotic resistance genes, from the urobiomes
of women with or without UTIs cannot be distinguished.
Furthermore, the E. coli genomes found within the urobiomes
of women with OAB and UUI, which have not been previously
studied, do not differ from E. coli genomes of isolates from
women with UTI symptoms. As our analysis shows, E. coli’s
ability to dominate the community and cause symptoms cannot
be associated with a gene or set of genes. While UTI can be the
result of colonization of E. coli, it is likely that UTI symptoms
can be caused by multiple different bacteria. Recent evidence
supports this hypothesis. The growing evidence of E. coli in the
urobiomes of women without UTI symptoms suggests that E. coli
may be a persistent member of the urinary community. This
suggests that other constituents of the urobiome may directly
or indirectly contribute to the development of UTI symptoms.
Future investigations of the etiology of UTI symptoms should
consider the entire urobiome.
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